{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,10]],"date-time":"2025-05-10T04:07:31Z","timestamp":1746850051848,"version":"3.40.5"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,5,9]]},"DOI":"10.7759\/cureus.83775","type":"journal-article","created":{"date-parts":[[2025,5,9]],"date-time":"2025-05-09T11:03:29Z","timestamp":1746788609000},"source":"Crossref","is-referenced-by-count":0,"title":["Myelofibrosis as an Unusual Cause of Back Pain: A Case Report"],"prefix":"10.7759","author":[{"given":"Richard","family":"Bechert","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1002\/art.34347","article-title":"A systematic review of the global prevalence of low back pain","volume":"64","author":"Hoy D","year":"2012","unstructured":"Hoy D, Bain C, Williams G, et al.. A systematic review of the global prevalence of low back pain. Arthritis Rheum. 2012, 64:2028-37. 10.1002\/art.34347","journal-title":"Arthritis Rheum"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200102013440508","article-title":"Low back pain","volume":"344","author":"Deyo RA","year":"2001","unstructured":"Deyo RA, Weinstein JN. Low back pain. N Engl J Med. 2001, 344:363-70. 10.1056\/NEJM200102013440508","journal-title":"N Engl J Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1111\/j.1525-1497.2001.91141.x","article-title":"Evaluating and managing acute low back pain in the primary care setting","volume":"16","author":"Atlas SJ","year":"2001","unstructured":"Atlas SJ, Deyo RA. Evaluating and managing acute low back pain in the primary care setting. J Gen Intern Med. 2001, 16:120-31. 10.1111\/j.1525-1497.2001.91141.x","journal-title":"J Gen Intern Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1007\/s00586-010-1502-y","article-title":"An updated overview of clinical guidelines for the management of non-specific low back pain in primary care","volume":"19","author":"Koes BW","year":"2010","unstructured":"Koes BW, van Tulder M, Lin CW, Macedo LG, McAuley J, Maher C. An updated overview of clinical guidelines for the management of non-specific low back pain in primary care. Eur Spine J. 2010, 19:2075-94. 10.1007\/s00586-010-1502-y","journal-title":"Eur Spine J"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12062188","article-title":"Myelofibrosis and survival prognostic models: a journey between past and future","volume":"12","author":"Duminuco A","year":"2023","unstructured":"Duminuco A, Nardo A, Giuffrida G, et al.. Myelofibrosis and survival prognostic models: a journey between past and future. J Clin Med. 2023, 12:2188. 10.3390\/jcm12062188","journal-title":"J Clin Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.26857","article-title":"Primary myelofibrosis: 2023 update on diagnosis, risk-stratification, and management","volume":"98","author":"Tefferi A","year":"2023","unstructured":"Tefferi A. Primary myelofibrosis: 2023 update on diagnosis, risk-stratification, and management. Am J Hematol. 2023, 98:801-21. 10.1002\/ajh.26857","journal-title":"Am J Hematol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-016-2208-2","article-title":"Myeloproliferative neoplasms (MPNs) have a significant impact on patients' overall health and productivity: the MPN Landmark survey","volume":"16","author":"Mesa R","year":"2016","unstructured":"Mesa R, Miller CB, Thyne M, et al.. Myeloproliferative neoplasms (MPNs) have a significant impact on patients' overall health and productivity: the MPN Landmark survey. BMC Cancer. 2016, 16:167. 10.1186\/s12885-016-2208-2","journal-title":"BMC Cancer"},{"key":"ref8","article-title":"Myelofibrosis: clinicopathologic features, prognosis, and management","volume":"16","author":"O\u2019Sullivan JM","year":"2018","unstructured":"O\u2019Sullivan JM, Harrison CN. Myelofibrosis: clinicopathologic features, prognosis, and management. Clin Adv Hematol Oncol. 2018, 16:121-31.","journal-title":"Clin Adv Hematol Oncol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1177\/20406207221084487","article-title":"A retrospective real-world study of the current treatment pathways for myelofibrosis in the United Kingdom: the REALISM UK study","volume":"13","author":"Mead AJ","year":"2022","unstructured":"Mead AJ, Butt NM, Nagi W, et al.. A retrospective real-world study of the current treatment pathways for myelofibrosis in the United Kingdom: the REALISM UK study. Ther Adv Hematol. 2022, 13:20406207221084487. 10.1177\/20406207221084487","journal-title":"Ther Adv Hematol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1002\/(sici)1096-8652(199905)61:1<10::aid-ajh3>3.0.co;2-i","article-title":"Population-based incidence and survival figures in essential thrombocythemia and agnogenic myeloid metaplasia: an Olmsted County Study, 1976-1995","volume":"61","author":"Mesa RA","year":"1999","unstructured":"Mesa RA, Silverstein MN, Jacobsen SJ, Wollan PC, Tefferi A. Population-based incidence and survival figures in essential thrombocythemia and agnogenic myeloid metaplasia: an Olmsted County Study, 1976-1995. Am J Hematol. 1999, 61:10-5. 10.1002\/(sici)1096-8652(199905)61:1&lt;10::aid-ajh3&gt;3.0.co;2-i","journal-title":"Am J Hematol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-017-3082-y","article-title":"The impact of myeloproliferative neoplasms (MPNs) on patient quality of life and productivity: results from the international MPN Landmark survey","volume":"96","author":"Harrison CN","year":"2017","unstructured":"Harrison CN, Koschmieder S, Foltz L, et al.. The impact of myeloproliferative neoplasms (MPNs) on patient quality of life and productivity: results from the international MPN Landmark survey. Ann Hematol. 2017, 96:1653-65. 10.1007\/s00277-017-3082-y","journal-title":"Ann Hematol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.26050","article-title":"Primary myelofibrosis: 2021 update on diagnosis, risk-stratification and management","volume":"96","author":"Tefferi A","year":"2021","unstructured":"Tefferi A. Primary myelofibrosis: 2021 update on diagnosis, risk-stratification and management. Am J Hematol. 2021, 96:145-62. 10.1002\/ajh.26050","journal-title":"Am J Hematol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.3390\/tomography9020038","article-title":"Characterizing the bone marrow environment in advanced-stage myelofibrosis during ruxolitinib treatment using PET\/CT and MRI: a pilot study","volume":"9","author":"Slot S","year":"2023","unstructured":"Slot S, Lavini C, Zwezerijnen GJ, et al.. Characterizing the bone marrow environment in advanced-stage myelofibrosis during ruxolitinib treatment using PET\/CT and MRI: a pilot study. Tomography. 2023, 9:459-74. 10.3390\/tomography9020038","journal-title":"Tomography"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2018.200832","article-title":"Characteristics and outcomes of patients with essential thrombocythemia or polycythemia vera diagnosed before 20 years of age: a systematic review","volume":"104","author":"Ianotto JC","year":"2019","unstructured":"Ianotto JC, Curto-Garcia N, Lauermanova M, Radia D, Kiladjian JJ, Harrison CN. Characteristics and outcomes of patients with essential thrombocythemia or polycythemia vera diagnosed before 20 years of age: a systematic review. Haematologica. 2019, 104:1580-8. 10.3324\/haematol.2018.200832","journal-title":"Haematologica"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1007\/s12308-015-0256-1","article-title":"Myeloproliferative neoplasms in children","volume":"8","author":"Hofmann I","year":"2015","unstructured":"Hofmann I. Myeloproliferative neoplasms in children. J Hematop. 2015, 8:143-57. 10.1007\/s12308-015-0256-1","journal-title":"J Hematop"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.revmed.2020.08.018","article-title":"Myelofibrosis: a review (Article in French)","volume":"42","author":"Genthon A","year":"2021","unstructured":"Genthon A, Killian M, Mertz P, Cathebras P, Gimenez De Mestral S, Guyotat D, Chalayer E. Myelofibrosis: a review (Article in French). Rev Med Interne. 2021, 42:101-9. 10.1016\/j.revmed.2020.08.018","journal-title":"Rev Med Interne"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.16576","article-title":"Myelofibrosis biology and contemporary management","volume":"191","author":"Gangat N","year":"2020","unstructured":"Gangat N, Tefferi A. Myelofibrosis biology and contemporary management. Br J Haematol. 2020, 191:152-70. 10.1111\/bjh.16576","journal-title":"Br J Haematol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2018026658","article-title":"MIPSS70+ v2.0 predicts long-term survival in myelofibrosis after allogeneic HCT with the Flu\/Mel conditioning regimen","volume":"3","author":"Ali H","year":"2019","unstructured":"Ali H, Aldoss I, Yang D, et al.. MIPSS70+ v2.0 predicts long-term survival in myelofibrosis after allogeneic HCT with the Flu\/Mel conditioning regimen. Blood Adv. 2019, 3:83-95. 10.1182\/bloodadvances.2018026658","journal-title":"Blood Adv"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.22021","article-title":"Palliative goals, patient selection, and perioperative platelet management: outcomes and lessons from 3 decades of splenectomy for myelofibrosis with myeloid metaplasia at the Mayo Clinic","volume":"107","author":"Mesa RA","year":"2006","unstructured":"Mesa RA, Nagorney DS, Schwager S, Allred J, Tefferi A. Palliative goals, patient selection, and perioperative platelet management: outcomes and lessons from 3 decades of splenectomy for myelofibrosis with myeloid metaplasia at the Mayo Clinic. Cancer. 2006, 107:361-70. 10.1002\/cncr.22021","journal-title":"Cancer"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1999.01213.x","article-title":"Magnetic resonance imaging in myelofibrosis and essential thrombocythaemia: contribution to differential diagnosis","volume":"104","author":"Rozman C","year":"1999","unstructured":"Rozman C, Cervantes F, Rozman M, Mercader JM, Montserrat E. Magnetic resonance imaging in myelofibrosis and essential thrombocythaemia: contribution to differential diagnosis. Br J Haematol. 1999, 104:574-80. 10.1046\/j.1365-2141.1999.01213.x","journal-title":"Br J Haematol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/346404-myelofibrosis-as-an-unusual-cause-of-back-pain-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,9]],"date-time":"2025-05-09T11:03:29Z","timestamp":1746788609000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/346404-myelofibrosis-as-an-unusual-cause-of-back-pain-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,9]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.83775","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5,9]]}}}